NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare ConferenceAccesswire • 09/01/21
NeoGenomics, Inc. (NEO) CEO Mark Mallon on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/06/21
Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to DeclineZacks Investment Research • 07/30/21
NeoGenomics Schedules its Second Quarter 2021 Earnings Release for August 6, 2021Accesswire • 07/14/21
NeoGenomics: Strong Growth Potential For A Leader In Cancer Diagnostic TestingSeeking Alpha • 07/02/21
NeoGenomics Completes Inivata Acquisition - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology PlatformAccesswire • 06/18/21
NeoGenomics (NEO) CEO Mark Mallon on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/06/21
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy Technology with Leading Community Oncology PlatformAccesswire • 05/05/21
NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer PatientsAccesswire • 04/19/21
NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare ConferenceAccesswire • 04/13/21
Strength Seen in NeoGenomics (NEO): Can Its 7.9% Jump Turn into More Strength?Zacks Investment Research • 04/01/21
NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE StudyAccesswire • 03/16/21
Elevation Oncology and NeoGenomics Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE StudyPRNewsWire • 03/16/21